Table 2.

Bisphenol-A by indices of glucose homeostasis in the study sample according to sex (n=1586)

	N (%a) or (Mean ± SEM) a	Bisphenol-A (ng/mL)	P*
Overall		Median (IQR)
Fasting glucose (mg/dL):	(104.3 ± 0.9)		0.55
≥100	774 (45.7)	1.9 (1.0, 3.6)
< 100	812 (54.3)	2.0 (1.0, 3.8)
Fasting insulin (μU/ml):	(11.4 ± 0.3)
HOMA-β:	(35.9 ± 0.9)
HOMA-IR:	(3.1 ± 0.1)		0.076
≥2.5	738 (41.7)	2.1 (1.1, 3.8)
< 2.5	848 (58.3)	1.8 (0.9, 3.7)
QUICKI:	(5.1 ± 0.006)
Males		Median (IQR)
Fasting glucose (mg/dL):	(106.3 ± 1.1)		0.62
≥100	445 (37.9)	2.0 (1.1, 3.5)
< 100	352 (62.1)	2.1 (1.1, 4.0)
Fasting insulin (μU/ml):	(11.9 ± 0.4)
HOMA-β:	(36.8 ± 1.4)
HOMA-IR:	(3.3 ± 0.1)		0.15
≥2.5	378 (38.1)	2.1 (1.2, 3.6)
< 2.5	419 (61.9)	2.0 (1.1, 3.9)
QUICKI:	(5.1 ± 0.009)
Females		Median (IQR)
Fasting glucose (mg/dL):	(102.5 ± 1.4)		0.48
≥100	329 (37.9)	1.7 (0.9, 3.8)
< 100	460 (62.1)	2.0 (0.9, 3.7)
Fasting insulin (μU/ml):	(11.0 ± 0.5)
HOMA-β:	(35.0 ± 1.3)
HOMA-IR:	(3.0 ± 0.2)		0.25
≥2.5	360 (38.1)	2.1 (1.0, 4.2)
< 2.5	429 (61.9)	1.7 (0.8, 3.4)
QUICKI:	(5.1 ± 0.007)

^aWeighted analyses;

^*P value for ANOVA test involving log-transformed bisphenol-A level with comparisons made across all categories of the covariates; IQR=Interquartile range; HOMA= Homeostasis Model Assessment; QUICKI= Quantitative Insulin Sensitivity Check Index.